MicroRNA-210 decreases heme levels by targeting ferrochelatase in cardiomyocytes
- PMID: 23608607
- PMCID: PMC3647255
- DOI: 10.1161/JAHA.113.000121
MicroRNA-210 decreases heme levels by targeting ferrochelatase in cardiomyocytes
Abstract
Background: MicroRNA-210 (miR-210) increases in hypoxia and regulates mitochondrial respiration through modulation of iron-sulfur cluster assembly proteins (ISCU1/2), a protein that is involved in Fe/S cluster synthesis VSports手机版. However, it is not known how miR-210 affects cellular iron levels or production of heme, another iron containing molecule that is also needed for cellular and mitochondrial function. .
Methods and results: To screen for micro-ribonucleic acids (miRNAs) regulated by iron, we performed a miRNA gene array in neonatal rat cardiomyocytes treated with iron chelators. Levels of miR-210 are significantly increased with iron chelation, however, this response was mediated entirely through the hypoxia-inducible factor (HIF) pathway V体育安卓版. Furthermore, miR-210 reduced cellular heme levels and the activity of mitochondrial and cytosolic heme-containing proteins by modulating ferrochelatase (FECH), the last enzyme in heme biosynthesis. Mutation of the 2 miR-210 binding sites in the 3' untranslated region (UTR) of FECH reversed the miR-210 response, while mutation of either binding site in isolation did not exert any effects. Changes mediated by miR-210 in heme and FECH were independent of ISCU, as overexpression of an ISCU construct lacking the 3' UTR does not alter miR-210 regulation of heme and FECH. Finally, FECH levels increased in hypoxia, and this effect was not reversed by miR-210 knockdown, suggesting that the effects of miR-210 on heme are restricted to normoxic conditions, and that the pathway is overriden in hypoxia. .
Conclusions: Our results identify a role for miR-210 in the regulation of heme production by targeting and inhibiting FECH under normoxic conditions V体育ios版. .
Figures











References
-
- Filipowicz W, Bhattacharyya SN, Sonenberg N. Mechanisms of post‐transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet. 2008; 9:102-114 - "VSports在线直播" PubMed
-
- Wang N, Zhou Z, Liao X, Zhang T. Role of microRNAs in cardiac hypertrophy and heart failure. IUBMB Life. 2009; 61:566-571 - PubMed
-
- Topkara VK, Mann DL. Role of microRNAs in cardiac remodeling and heart failure. Cardiovasc Drugs Ther. 2011; 25:171-182 - VSports注册入口 - PubMed
-
- Daubman S. MicroRNAs in angiogenesis and vascular smooth muscle cell function. Circ Res. 2010; 106:423-425 - V体育2025版 - PubMed
VSports app下载 - Publication types
MeSH terms
- "VSports注册入口" Actions
- Actions (V体育官网入口)
- V体育安卓版 - Actions
- "V体育平台登录" Actions
- V体育ios版 - Actions
- "VSports在线直播" Actions
- Actions (V体育ios版)
- Actions (VSports手机版)
- "VSports手机版" Actions
Substances
- V体育ios版 - Actions
- "V体育官网入口" Actions
- "V体育2025版" Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous